# uMed

> uMed is a health-data company that plants software inside networks of doctors' practices, care providers, and health systems, then wires it straight into electronic health records. That lets it assemble consented, longitudinal patient cohorts in days instead of months and feed pharma and researchers the real-world evidence that older databases simply do not hold. Founded in 2018 by former NHS anaesthetist Dr Matt Wilson, it has raised roughly $17-25M and links records from around 10 million patients across the UK, US, and Australia.

- **Founded:** 2018
- **Headquarters:** London, United Kingdom
- **Founders:** Dr Matt Wilson (Founder & CEO)
- **Team size:** ~93 employees
- **Products:** ACCESS Cohorts, ACCESSPD, ACCESSILD / Lung Disease Cohort, ACCESSCMD, Study Services (Recruit & Collect)
- **Notable:** Linked EHR records from approximately 10 million patients across the UK, US, and Australia, 6,000+ patients enrolled in clinical studies, Raised a £9.8M Series A in July 2023 amid a widely reported collapse in UK clinical trial activity

## Products & services

- **ACCESS Cohorts** — Reusable, longitudinal research registries that link routine EHR records with scalable patient-reported outcomes, giving researchers custom evidence that does not exist in established databases.
- **ACCESSPD** — Parkinson's Disease registry combining near real-time EHR data with prospective patient-reported data and biosamples collected at home.
- **ACCESSILD / Lung Disease Cohort** — Interstitial lung disease registry, including pulmonary fibrosis, developed with the Three Lakes Foundation.
- **ACCESSCMD** — Cardiometabolic disease registry for large-scale real-world evidence generation.
- **Study Services (Recruit & Collect)** — End-to-end decentralized trial support: automated patient recruitment, remote consent, home data collection, and a single-patient-view dashboard.

## Achievements

- Linked EHR records from approximately 10 million patients across the UK, US, and Australia
- 6,000+ patients enrolled in clinical studies
- Raised a £9.8M Series A in July 2023 amid a widely reported collapse in UK clinical trial activity
- ISO 27001, ISO 9001, Cyber Essentials Plus, HIPAA, and NHS DSPT certified
- Selected founder as an NHS England Clinical Entrepreneur Fellow
- Featured by TechRound as a top UK medtech startup

## Latest updates

- **2025-12** — Launched a nationwide US partnership with WellSky to bring clinical research registries into home-based care settings, targeting rural, aging, and underserved populations.
- **2024-09** — Dr Matt Wilson featured in a podcast on the untold benefits of health data collection and sharing.
- **2023-07** — Raised £9.8M Series A and announced North America expansion via Innovaccer (US) and MCI Onehealth (Canada).

## Links

- Website: https://umed.io
- LinkedIn: https://uk.linkedin.com/company/umedeor
- Twitter/X: https://twitter.com/umed_io
- YouTube: https://www.youtube.com/watch?v=JLcKSZJifq4

---

Profile page: https://yespress.io/umed
Published by YesPress — https://yespress.io
Last updated: 2026-08-20